Anti-Human IGHE Recombinant Antibody(Tanezumab)
-
产品编号
YR1147
-
别名
科研级 Tanezumab ( 他尼组单抗 ), Anti-IGHE Recombinant Antibody, Research Grade Tanezumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Tanezumab ( 他尼组单抗 ), Anti-IGHE Recombinant Antibody, Research Grade Tanezumab |
Catalog Number | YR1147 |
Molecular Name | Tanezumab |
Host | Mouse |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 |
Formulation | PBS, pH7.5 |
Background | Tanezumab (INN, codenamed RN624) is a monoclonal antibody against nerve growth factor as a treatment for pain. Tanezumab was discovered and developed by Rinat Neuroscience and was acquired by Pfizer in 2006. |
CAS Number | 880266-57-9 |
Application | ELISA, FuncS, Inhib |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | IGHE[Homo sapiens] |